Navigation Links
New radiotherapy approach reduces symptoms of dry mouth in patients with head and neck cancers
Date:4/20/2013

glands were significantly higher at six weeks and at one year in patients who received a dose to the submandibular gland of less than 40 Gy, and this translated into fewer complaints of dry mouth. Using the new technique, we managed to keep the dose under 40 Gy in 50 percent of the patients," said Dr Terhaard. "Now we are looking for further improvements, since in 50 percent of the patients the dose to the submandibular glands was still too high."

The researchers found that all but one of the patients who could be treated with radiation doses of less than 40 Gy to the submandibular gland were the patients who had small tumours (less than 4cms in diameter). These patients consequently had fewer problems with xerostomia after a year.

"If the tumour is more advanced larger than 4cms or with the contralateral lymph nodes involved the distance from the tumour to the contralateral submandibular gland may become too small to spare this gland," said Dr Terhaard.

"This is the largest detailed study to show the correlation between the dose to the submandibular gland and the measured output of the contralateral submandibular gland. It is the first study to show subjectively and objectively that when you reduce the dose to the submandibular gland, the patients have fewer severe complaints. This leads to a guideline, which can be used in clinical practice, of the recommended maximum dose of 40 Gy for the submandibular gland. It also shows that with improved techniques, such as IMRT, you may better spare the submandibular gland, as well the parotid glands," he concluded.

President of ESTRO, Professor Vincenzo Valentini, a radiation oncologist at the Policlinico Universitario A. Gemelli, Rome, Italy, commented: "The translation of a dosimetry benefit into a clinical benefit is of definitive relevance in the era of highly sophisticated radiotherapy. There is a new generation of studies becoming available that aims to confirm the impact of the
'/>"/>

Contact: Emma Mason (media enquiries only)
wordmason@mac.com
European Society for Radiotherapy and Oncology (ESTRO)
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Surgery is superior to radiotherapy in men with localized PCa, says prize-winning Swedish study
2. Promising new drug treats and protects against radiotherapy-associated oral mucositis
3. Sniffing out the side effects of radiotherapy may soon be possible
4. 1 out of 4 lung cancer patients in Andalusia does not receive the radiotherapy they need
5. Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
6. Potential new technique for anticancer radiotherapy could provide alternative to brachytherapy
7. RI Hospital researcher: Older women may not benefit from radiotherapy after breast surgery
8. Quality of life study shows stereotactic ablative radiotherapy effective treatment; stage I NSCLC
9. Breathing during radiotherapy - how to hit the treatment target without causing collateral damage
10. Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
11. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Results ... Navigant Center for Healthcare Research and Policy Analysis show widespread support for the ... said they agreed or strongly agreed that the controversial law passed in 2010 ...
(Date:8/3/2015)... ... August 03, 2015 , ... It’s 25 miles from ... California’s northernmost and among its least visited State Parks. The volcanic area beneath ... outflow is at Ahjumawi Lava Springs, part of the Fall River Springs complex. ...
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... AZ (PRWEB) , ... August 03, 2015 , ... Dignity ... Dignity Health Arizona General Hospital Emergency Room – Gilbert, opening in August. The ... earlier this year in the West Valley. , “Dr. Baldwin is an excellent ...
(Date:8/3/2015)... ... 2015 , ... Cambia Health Solutions has promoted Scott Powers ... Medicare and Federal Employee Programs (FEP) lines of business. , Government programs ... In this role, Scott is responsible for overseeing the growth, finance and operations ...
Breaking Medicine News(10 mins):Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2
... Pharmasset, Inc.,(Nasdaq: VRUS ) management will present ... being held from May 19-20, 2008 at the Le,Meridien ... Chief Executive Officer, will provide an overview of the,company ... in the Zephyr Salon., To access a simultaneous ...
... Foundation to celebrate,scientific advancements that have fueled longer life ... To celebrate,remarkable progress in treating cystic fibrosis -- ... the Cystic Fibrosis Foundation,to join the company as honored ... Life expectancy for people with CF has more than ...
... Company Prepares for, Potential 2008 Launch of MOXATAG; Keflex Product Sales ... ... in Quarter, GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: ... anti-infective products, today,announced financial and operational results for the quarter ended ...
... impact EPA,s clean air regulations, researchers say , , TUESDAY, ... particles, such as those found in windblown dust or ... not appear to be linked to hospital admissions, a ... for short, is between 2.5 and 10 micrometers or ...
... studies report, , , TUESDAY, May 13 (HealthDay News) -- New ... breast cancer risk. , The bad news is a ... with breast cancer face an increased risk of breast cancer ... according to a study in the May 13 issue of ...
... used to treat a rare but well-known genetic disorder may ... with potentially lethal enlarged hearts, due mainly to high blood ... The common denominator in both phenylketonuria (PKU) and cardiac hypertrophy ... coworker helps break down the molecule phenylalanine whose buildup is ...
Cached Medicine News:Health News:Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th 2Health News:Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:No Link Between Coarse Air Pollution, Hospitalizations 2Health News:Familial Breast Cancer Risk Lasts a Lifetime for Sisters 2Health News:Familial Breast Cancer Risk Lasts a Lifetime for Sisters 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4
(Date:8/3/2015)... Aug. 3, 2015  Array BioPharma Inc. (NASDAQ: ... fourth quarter and full year of its fiscal ... Squarer, Chief Executive Officer of Array, noted, "Binimetinib and ... are on track for regulatory submissions in 2016. ... melanoma and BRAF-mutant colorectal cancer further validate the ...
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, 2015 /PRNewswire/ ... primary and secondary endpoints in a phase III study ... in adult patients with chronic non-cancer pain. Naldemedine is ... This is the third Phase III trial in which ... Study results showed that a 0.2 mg tablet ...
(Date:8/3/2015)... ST. PAUL, Minn. , Aug. 3, 2015 /PRNewswire/ ... devices using neuroblocking therapy to treat obesity, metabolic diseases ... C. McDougal has been appointed to the Board ... serve as a Class II Director until the 2018 ... qualified. Ms. McDougal has served in an ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3
... of Novel Proteasome Inhibitor in ... Patients with Relapsed Solid Tumors, SOUTH SAN ... South Texas Accelerated Research Therapeutics (START),today announced the enrollment of ... Proteolix,s investigational drug, carfilzomib (PR-171).,START is participating in the study ...
... Protects the Ocular Surface Following Exposure to ... Dry Eye Symptoms, LAGUNA HILLS, Calif., Oct. 9 ... ALTY-0501, demonstrated statistically,significant advantages over vehicle in its ability ... Phase 2 study. The Phase 2 study utilized ...
Cached Medicine Technology:Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors 2Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors 3Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501 2Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501 3
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
... Family offers fast temperature control, exact block ... Personal cards enable safe program storage as ... individual protocols between different Mastercyclers. All models ... come with a two-year warranty. The ...
... 96 well thermocycler with ... Peltier technology for fastest available ... to 4C/sec with High Pressure ... PCR plates. Includes motorized ...
... graphical touch screen display which enables you ... of a screen." Features & Benefits ... Graphical Display, Memory Cards, Gradient Calculator, Fold ... Programmin, Free Instrument Software Upgrade. Includes ...
Medicine Products: